May contain inaccuracies · Check primary sources · Not medical advice · Not for human or animal use

Non-peptide

Agomelatine

Also known as

Valdoxan · Thymanax

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

Agomelatine is an antidepressant people discuss for low mood, disrupted sleep and getting their motivation back. Some describe easier nights and more interest in daily life; others feel no benefit, wake too early or become more anxious. These patient experiences do not establish a cognitive or performance boost in healthy people.

What agomelatine is

  • Valdoxan is a medicine containing agomelatine. It is a non-peptide prescription antidepressant, supplied as oral tablets and authorized in Europe for major depressive episodes in adults. Brand names identify products; a supplier listing does not verify what a particular sample contains. Official context
  • Thymanax is a historical brand alias. EMA records withdrawal of its EU authorization in July 2022 for commercial reasons. It identifies the same active substance, not a separate research compound. Official context
  • Sleep and mood can change differently. KatieD33, also using Ativan, found bedtime easier at 25 mg but later still reported little improvement beyond sleep. This is why a sleep benefit alone should not be described as broad emotional or cognitive improvement. Reddit
  • It acts on melatonin and serotonin receptors. The label describes activation of melatonin receptors MT1/MT2 and blockade of serotonin receptor 5-HT2C. This explains the interest in sleep and mood; receptor activity alone does not predict a productive day or an antidepressant response. Official context

Benefits people report

  • More interest in ordinary life. The six-week author described more exercise, less emotional eating and less severe mood lows, with anxiety improving less. They also disclosed occasional psilocybin use and changed daily habits, so the account cannot isolate agomelatine or establish an ADHD or weight-loss effect. Reddit
  • Easier sleep can be the main benefit. Troppo described an earlier bedtime after a severely delayed sleep pattern, despite earlier disappointment with melatonin. Alprazolam, phenibut and quetiapine continued alongside it; this is a mixed-medication experience, not proof of a stronger sleep aid. Personal report
  • A better night can still come with a difficult day. A Patient Communities writer returned to agomelatine after SSRI side effects but described disabling tiredness while also taking quetiapine. Co-use makes the cause uncertain. Personal report

How people compare it

  • Melatonin is the nearest sleep comparison. Troppo reported earlier sleep with agomelatine after melatonin had disappointed them. Concurrent sedatives make that personal comparison unsuitable for ranking the drugs. Personal report
  • SSRI comparisons often concern tolerability. The Patient Communities writer described problems during an SSRI switch as well as fatigue after returning to agomelatine. Different side effects do not establish that one option is safer or better overall. Personal report

Doses people discuss

Reported amounts, not a regimen. These posts concern medicine taken in tablet-use contexts; none establishes an injectable, nasal or sublingual dose. Milligrams here refer to the named drug, not an entire stack.

  • 25 mg appears in tablet-use accounts. KatieD33 describes this amount for six weeks before a change to 50 mg. The posts establish tablet context but do not consistently document exact daily frequency; no daily total is inferred. Reddit
  • 50 mg does not consistently improve sleep. The early-waking OP describes worse sleep after moving from 25 mg to 50 mg and continuing trouble after returning. That is one person’s sequence, not a dose ladder. Reddit
  • 37.5 mg appears as a single experiment. Built240 reports trying it after 25 mg had felt ineffective. A proposed later 50 mg trial was not demonstrated in the inspected follow-up, which instead described stopping; proposed amounts must not be counted as completed use. Reddit

Half-life: what these reports can tell us

  • No blood half-life was measured in these accounts. Bedtime sleepiness, early waking and next-day feelings do not show when the amount in blood halves. The reviewed posts provide experiences rather than a verified community measurement; the labeled plasma figure is kept in formal context below. Reddit Reddit

When people notice a change

  • Sleep changes can appear early, or take weeks. Troppo noticed no first-night change but earlier sleep from the second night. Busy_Cranberry7704 instead recalled about a month before meaningful sleep improvement; different people and co-medications prevent a single dependable onset window. Personal report Reddit
  • Mood changes may take several weeks. georgiee108 describes 3–4 weeks for mood and sleep improvement. The OP of that discussion instead felt worse after about a week; a positive reply cannot determine how long someone else should persist. Reddit

How long the reported effects last

  • Falling asleep does not guarantee staying asleep. The early-waking OP still woke at 5 a.m. Troppo also woke during the night but could return to sleep; neither report supplies a fixed number of hours of drug effect. Reddit Personal report
  • Follow-up periods describe repeated use. KatieD33’s nine-week update still emphasized sleep over mood benefit. Weeks on treatment are not the duration of one dose, and do not establish how long benefit lasts after stopping. Reddit

Continued use, breaks and stopping

  • Long use is reported, without a standard cycle. Busy_Cranberry7704 reports continuing six years after starting. One retrospective history cannot establish an optimal course or a planned break schedule. Reddit
  • Skipping doses is not evidence for a useful reset. One six-week-thread commenter reported skipping a day or two because sleep felt worse despite a slight mood improvement. That describes difficulty tolerating the medicine, not proof that intermittent use works better. Reddit

What needs particular care

  • Liver monitoring is a material risk requirement. MHRA calls for blood tests before treatment and at weeks 3, 6, 12 and 24, with later checks when indicated. Its warning calls for stopping and immediate medical help for suspected liver injury, including jaundice or dark urine. Official context
  • Other medicines can change exposure. Fluvoxamine and ciprofloxacin are contraindicated combinations; alcohol is discouraged. A forum claim that a stack has no interactions is not a safety check. The current label also excludes active liver disease and renews liver monitoring after dose increases. It warns about dizziness and drowsiness when driving. Official context
  • Worsening mood is not something to dismiss as adjustment. The label calls for immediate medical advice for worsening symptoms, suicidal thoughts or unusual behavior, and cautions about mania. The difficult-start OP reported worsening distress with pregabalin and escitalopram co-use; cause remains uncertain. Official context Reddit
  • Dreams, dizziness and next-day fatigue can be disruptive. wareson reported disturbing dreams and days of dizziness. The Patient Communities writer described difficulty functioning during quetiapine co-use; neither account gives a dependable duration of impairment. Reddit Personal report

What the community accounts add

  • A quieter mind can still mean less motivation. Chaos-Kitty2401 described fewer racing thoughts and panic attacks, but also less activity, fewer interests and continuing insomnia. That mixed account matters alongside enthusiastic reports of getting routines back; calmness and useful functioning are different outcomes. Reddit
  • Nootropic expectations can outrun the experience. Built240 hoped for a stimulant-like lift and reported none, amid amphetamine use and an escitalopram history. The account does not test enhancement in a healthy, otherwise unmedicated person. Reddit
  • Brand comparisons are personal impressions. Fapping-sloth preferred Valdoxan to a generic tried briefly. There was no blinded comparison or verified product analysis, so the story cannot establish that generics fail, or validate an unrelated supplier’s product. Reddit
  • No effect is also reported. Vanilla_Kestrel reported neither relief nor side effects. That null experience remains alongside the positive and adverse accounts; this small, self-selected sample cannot establish response rates. Reddit
  • A liver-test story can be misread. CannedTuma described a doctor’s concern about abnormal baseline tests after briefly starting treatment. Because the tests were baseline measurements, this is not evidence that agomelatine caused liver injury in two days; it illustrates why the timing of a test matters. Reddit
  • An early lift can reverse. OkCar5485 initially described more energy after 50 mg, then agitation. A later update said returning to 25 mg did not clearly help and they stopped; this is one evolving account, not two independent outcomes. Reddit

Separately labeled medical context

  • The labeled plasma half-life is 1–2 hours. This is the mean elimination half-life in product pharmacokinetics, not a measured duration of sleep, mood relief or next-day impairment in a forum user. Official context
  • Approval concerns depression, not general enhancement. EMA describes prescription treatment for major depressive episodes in adults. That indication does not establish a benefit for healthy-person cognition, ADHD, bodybuilding or a supplier’s alternative formulation. Official context

Open in the directory ↗All STUDresearch topics →